Brevan Howard Capital Management LP Castle Biosciences Inc Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q2 2025
A detailed history of Brevan Howard Capital Management LP transactions in Castle Biosciences Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 41,301 shares of CSTL stock, worth $999,897. This represents 0.01% of its overall portfolio holdings.
Number of Shares
41,301
Previous 12,205
238.39%
Holding current value
$999,897
Previous $244,000
245.49%
% of portfolio
0.01%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CSTL
# of Institutions
170Shares Held
27.9MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.04MShares$73.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$52.5 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.8MShares$43.6 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.49MShares$36.1 Million2.2% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.38MShares$33.4 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $637M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...